Navneet Majhail
@bldcancerdoc.bsky.social
Physician-in-Chief of Blood Cancers, Sarah Cannon Cancer Network | President ASTCT 2019 | #BMTsm #CARTcell #CellTherapy
That is a 50% success rate - pretty high for academic medicine! 😀
April 15, 2025 at 12:46 PM
That is a 50% success rate - pretty high for academic medicine! 😀
Congratulations Gunjan (PS: @drmiguelperales.bsky.social have her join @bsky.app 🙏)
March 31, 2025 at 2:54 PM
Congratulations Gunjan (PS: @drmiguelperales.bsky.social have her join @bsky.app 🙏)
Is that 1/10 centers that already offer cell therapy? We onboard new CART companies and products all the time - would love to hear what the discussion was around why centers who can do this are not getting on board with the TCR product for synovial sarcoma.
March 26, 2025 at 3:03 AM
Is that 1/10 centers that already offer cell therapy? We onboard new CART companies and products all the time - would love to hear what the discussion was around why centers who can do this are not getting on board with the TCR product for synovial sarcoma.